Français
ItalianoBond GSK PLC 4.5% ( US377372AP29 ) in USD
| Issuer | GSK PLC | ||||
| Market price |  100.00 % ▲ |
||||
| Country |  United Kingdom
|
||||
| ISIN code |
 US377372AP29 ( in USD )
|
||||
| Interest rate | 4.5% per year ( payment 2 times a year) | ||||
| Maturity | 15/04/2030 | ||||
|
Prospectus brochure in PDF format |
|||||
| Minimal amount | / | ||||
| Total amount | / | ||||
| Cusip | 377372AP2 | ||||
| Standard & Poor's ( S&P ) rating | A ( Upper medium grade - Investment-grade ) | ||||
| Moody's rating | A2 ( Upper medium grade - Investment-grade ) | ||||
| Next Coupon | 15/10/2026 ( In 29 days ) | ||||
| Detailed description |
GSK PLC is a British multinational pharmaceutical and biopharmaceutical company headquartered in Brentford, UK, focused on research and development, manufacturing, and marketing of pharmaceuticals, vaccines, and consumer healthcare products globally. The Bond issued by GSK PLC ( United Kingdom ) , in USD, with the ISIN code US377372AP29, pays a coupon of 4.5% per year. The coupons are paid 2 times per year and the Bond maturity is 15/04/2030 The Bond issued by GSK PLC ( United Kingdom ) , in USD, with the ISIN code US377372AP29, was rated A2 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by GSK PLC ( United Kingdom ) , in USD, with the ISIN code US377372AP29, was rated A ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||
| |||||